Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Ministry of Science and Technology, Taiwan | OTHER_GOV |
Not provided
Not provided
Not provided
Not provided
This is a cross-sectional research. The Protection Motivation Theory (PMT) was applied as theoretical framework to analyze correlation of prevention knowledge, prevention intentions and anxiety, and prevention behavior of COVID-19 and HIV risk feature and behavior and stigma of people living with HIV/AIDS (PLWHA), and HIV high-risk groups. Purposive and snowball sampling will be applied to recruit participant who visit hospital, HIV/AIDS related institutions, and social media platforms. The investigators expect that the outcome could reveal the relationship of cognition and attitude of COVID-19 to HIV prevention and treatment.
The prevention strategies can effectively block the spread of Coronavirus disease (Coronavirus disease 19; COVID-19), and at the same time may indirectly reduce or increase the risk behaviors and factors of Human Immunodeficiency Virus (HIV) and sexually transmitted comorbidities. The main purpose of this research is to apply the Protection Motivation Theory (PMT) as the framework to analyze COVID-19 prevention knowledge, COVID-19 prevention intentions and anxiety level, and COVID-19 prevention behavior and HIV risk behavior and risk factors of people living with HIV/AIDS (PLWHA) and HIV high-risk groups. The cross-sectional research method was adopted, and the subjects included the northern, central, southern, and eastern regions of Taiwan.About 1100 PLWHA and 1100 high-risk groups will be recruited. The information of recruitment will be disseminated through the AIDS designated medical institutions and related institutions, and social media, Snowball recruitment of interviewees will also be used. After completing the online questionnaire, the structural equation modeling (SEM) will be applied to test the good of fit of the theory model and to explain the structural relationship between COVID-19 prevention knowledge, attitudes, behaviors and HIV risk factors. The relationship with the above variables and stigma also been discussed. In addition to verifying the theories proposition of PMT, the research results also contribute to the prevention and treatment of HIV high-risk groups, and provide important references for prevention strategies for susceptible groups during the epidemic of emerging infectious diseases in the future.
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| COVID-19 prevention knowledge | The questionnaire of COVID-19 prevention knowledge will be used to measure the knowledge level. | Through study completion, an average of one and half year |
| COVID-19 prevention intention and anxiety | The questionnaire of COVID-19 prevention intention and anxiety will be used to measure the attitude level. | Through study completion, an average of one and half year |
| COVID-19 prevention behavior | The questionnaire of COVID-19 prevention behavior will be used to measure the behavior level. | Through study completion, an average of one and half year |
| Stigma | The questionnaire of stigma will be used to measure the stigma level of HIV infected people. | Through study completion, an average of one and half year |
| HIV risk factor and behavior | The questionnaire of HIV risk factor and behavior will be used to measure the risk condition during COVID-19 era. | Through study completion, an average of one and half year |
Not provided
Not provided
Inclusion Criteria for HIV/AIDS participants:
Exclusion Criteria for HIV/AIDS participants:
1. Participants who can't read and communicate.
Inclusion Criteria for HIV high risk group:
Exclusion Criteria for HIV high risk group:
1. Participants who can't read and communicate.
Not provided
Not provided
Not provided
Two study populations will be incruited in this research:
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| PIAO-YI CHIOU, doctoral | Contact | +886-2-23123456 | 88427 | piaoyi@ntu.edu.tw |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| School of Nursing of National Taiwan University | Recruiting | Taipei | 100 | Taiwan |
| Type | Date | Date Unknown |
|---|---|---|
| Release | Aug 10, 2023 | |
| Reset | Mar 7, 2024 | |
| Release | Apr 18, 2024 | |
| Reset | Sep 12, 2024 | |
| Release | Jul 25, 2025 | |
| Reset | Aug 11, 2025 | |
| Release | Aug 18, 2025 | |
| Reset | Sep 5, 2025 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Aug 10, 2023 | Mar 7, 2024 | |||
| Apr 18, 2024 |
| ID | Term |
|---|---|
| D000086382 | COVID-19 |
| D000163 | Acquired Immunodeficiency Syndrome |
| D001519 | Behavior |
| D057545 | Social Stigma |
| ID | Term |
|---|---|
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
| Sep 12, 2024 |
| Jul 25, 2025 | Aug 11, 2025 |
| Aug 18, 2025 | Sep 5, 2025 |
| D014777 |
| Virus Diseases |
| D018352 | Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D015658 | HIV Infections |
| D000086982 | Blood-Borne Infections |
| D003141 | Communicable Diseases |
| D015229 | Sexually Transmitted Diseases, Viral |
| D012749 | Sexually Transmitted Diseases |
| D016180 | Lentivirus Infections |
| D012192 | Retroviridae Infections |
| D012897 | Slow Virus Diseases |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D007153 | Immunologic Deficiency Syndromes |
| D007154 | Immune System Diseases |
| D012919 | Social Behavior |